沸点	290 ºC
闪点	124 ºC
密度	1.091
折射率	1.054-1.059

没有数据	没有数据

来源	SDS样本
Oakwood	浏览或下载
Matrix	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

[Pharmacological and clinical properties of didanosine (VIDEX), a nucleoside reverse transcriptase inhibitor].Masahiko Okiyama et al.Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 120(2), 115-122 (2002-08-22) Update on didanosine.David A Cooper Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 1(1), 15-25 (2003-08-29) Toxic interaction of didanosine and acetaminophen leading to severe hepatitis and pancreatitis: a case report and review of the literature.J C Lederman et al.The American journal of gastroenterology, 96(12), 3474-3475 (2002-01-05) Didanosine: an updated review of its use in HIV infection.C M Perry et al.Drugs, 58(6), 1099-1135 (2000-01-29) Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine.R J De Boer et al.AIDS (London, England), 12(13), 1567-1570 (1998-10-09) Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.Hui-Min Chang et al.Japanese journal of infectious diseases, 65(1), 61-65 (2012-01-26) The role of didanosine in the management of HIV-1 infection.B G Gazzard et al.Antiviral therapy, 2(3), 135-147 (1997-07-01) Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.M Masiá et al.International journal of STD & AIDS, 16(9), 646-648 (2005-09-24) Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.J Darbyshire et al.The Cochrane database of systematic reviews, (3)(3), CD002038-CD002038 (2000-07-25) Effect of tenofovir on didanosine absorption in patients with HIV.Patricia Pecora Fulco et al.The Annals of pharmacotherapy, 37(9), 1325-1328 (2003-08-19) Peripheral neuropathy in HIV: an analysis of evidence-based approaches.Patrice K Nicholas et al.The Journal of the Association of Nurses in AIDS Care : JANAC, 25(4), 318-329 (2014-04-05) Didanosine. An update on its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV disease.C M Perry et al.Drugs, 52(6), 928-962 (1996-12-01) Didanosine once daily: an overview.M Youle Antiviral therapy, 3 Suppl 4, 35-37 (2000-03-21) Tenofovir and didanosine: a dangerous liaison.Laura Waters et al.The AIDS reader, 15(8), 403-406 (2005-08-23) Systematic review of combination antiretroviral therapy with didanosine plus hydroxyurea: a partial solution to Africa's HIV/AIDS problem?I Sanne et al.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 5(1), 43-48 (2001-04-04) Didanosine once daily: potential for expanded use.R B Pollard AIDS (London, England), 14(16), 2421-2428 (2000-01-11) Didanosine enteric-coated capsule: current role in patients with HIV-1 infection.Santiago Moreno et al.Drugs, 67(10), 1441-1462 (2007-06-30) Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications.Richard M Hoglund et al.British journal of clinical pharmacology, 79(4), 636-649 (2014-10-10) Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients.Rosario Palacios et al.Expert review of anti-infective therapy, 4(6), 965-971 (2006-12-22) Bioretrosynthetic construction of a didanosine biosynthetic pathway.William R Birmingham et al.Nature chemical biology, 10(5), 392-399 (2014-03-25) Overview of the preclinical development of an antiretroviral drug, 2',3'-dideoxyinosine.J J McGowan et al.Reviews of infectious diseases, 12 Suppl 5, S513-S520 (1990-07-01) Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review.Géraldine D'Ythurbide et al.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22(12), 3656-3659 (2007-10-02) Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.J Darbyshire et al.The Cochrane database of systematic reviews, (2)(2), CD002038-CD002038 (2000-05-05) Tenofovir plus didanosine as Nrti backbone in HIV-infected subjects.Marco Bongiovanni et al.Current medicinal chemistry, 13(23), 2789-2793 (2006-11-01) Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: implication for mitochondrial toxicities of anti-HIV nucleoside analogs.Sun R, Eriksson S, and Wang L Biochemical and Biophysical Research Communications, 450(2), 1021-1026 (2014)

备注